Abe, S., Hanyu, H., Arai, H, Iwamoto, T, and Takasaki, M. (1996). Cerebral hemodynamics in patients with dementia]. Nippon Ronen Igakkai Zasshi, 33: 95-104.
Adlam, A. L., Patterson, K., Rogers, T. T., Nestor, P. J., Salmond, C. H., Acosta-Cabronero, J. et al. (2006). Semantic dementia and fluent primary progressive aphasia: two sides of the same coin? Brain, 129: 3066-3080.
Aharon-Peretz, J., Peretz, A., Hemli, J. A., Honigman, S., and Israel, O. (1995). SPECT diagnosis of Creutzfeld-Jacob disease. Journal of Nuclear Medicine, 36: 616-617.
Alexander, G. E., Prohovnik, I., Sackeim, H. A., Stern. Y., and Mayeux, R. (1995). Cortical perfusion and gray matter weight in frontal lobe dementia. The Journal of Neuropsychiatry and Clinical Neurosciences, 7: 188-196.
Alvarez-Sauco, M., Molto-Jorda, J. M., Morera-Guitart, J., Frutos-Alegria, M. T., and Matias-Guiu Guia, J. (2005). An update on the diagnosis of vascular dementia. Revista de Neurologia, 41: 484-492.
Amici, S., Gorno-Tempini, M. L., Ogar, J. M., Dronkers, N. F., and Miller, B. L. (2006). An overview on Primary Progressive Aphasia and its variants. Behavioural Neurology, 17: 77-87.
Appollonio, I., Frisoni, G. B., Curto, N., Trabucchi, M., and Frattola, L. (1997). Which diagnostic procedures in the elderly? The case of late-onset Huntington's disease. Journal of Geriatric Psychiatry and Neurology, 10: 39-46.
Arata, H., Takashima, H., Hirano, R., Tomimitsu, H., Machigashira, K., Izumi, K. et al. (2006). Early clinical signs and imaging findings in Gerstmann-Straussler-Scheinker syndrome (Pro102Leu). Neurology, 66: 1672-1678.
Arnold, G., Tatsch, K., Oertel, W. H., Vogl, T., Schwarz, J., Kraft, E. et al. (1994). Clinical progressive supranuclear palsy: differential diagnosis by IBZM-SPECT and MRI. Journal of Neural Transmission. Supplementum, 42: 111-118.
Baezner, H. and Daffertshofer, M. (2003). Subcortical vascular encephalopathy. Therapeutische Umschau. Revue thérapeutique, 60: 541-552.
Barnes, A., Lusman, D., Patterson, J., Brown, D., and Wyper, D. (2000). The use of statistical parametric mapping (SPM96) as a decision aid in the differential diagnosis of dementia using 99mTc-HMPAO SPECT. Behavioural Neurology, 12: 77-86.
Barnes, J., Godbolt, A. K., Frost, C., Boyes, R. G., Jones, B. F., Scahill, R. I. et al. (2007). Atrophy rates of the cingulate gyrus and hippocampus in AD and FTLD. Neurobiology of Aging, 28: 20-28.
Bavis, J., Reynolds, P., Tegeler, C., and Clark, P. (2003). Asymmetric neuroimaging in Creutzfeldt-Jakob disease: A ruse. Journal of Neuroimaging, 13: 376-379.
Berding, G., Odin, P., Brooks, D. J., Nikkhah, G., Matthies, C., Peschel, T. et al. (2001). Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET. Movement Disorders, 16: 1014-1022.
Berent, S., Giordani, B., Lehtinen, S., Markel, D., Penney, J. B., Buchtel, H. A. et al. (1988). Positron emission tomographic scan investigations of Huntington's disease: Cerebral metabolic correlates of cognitive function. Annals of Neurology, 23: 541-546.
Bergman, H., Chertkow, H., Wolfson, C., Stern, J., Rush, C., Whitehead, V. et al. (1997). HM-PAO (CERETEC) SPECT brain scanning in the diagnosis of Alzheimer's disease. Journal of the American Geriatrics Society, 45: 15-20.
Bohnen, N. I., Kaufer, D. I., Ivanco, L. S., Lopresti, B., Koeppe, R. A., Davis, J. G. et al. (2003). Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Archives of Neurology, 60: 1745-1748.
Bokde, A. L., Pietrini, P., Ibanez, V., Furey, M. L., Alexander, G. E., Graff-Radford, N. R. et al. (2001). The effect of brain atrophy on cerebral hypometabolism in the visual variant of Alzheimer disease. Archives of Neurology, 58: 480-486.
Bonte, F. J., Harris, T. S., Hynan, L. S., Bigio, E. H., and White, C. L., 3rd. (2006). Tc-99m HMPAO SPECT in the differential diagnosis of the dementias with histopathologic confirmation. Clinical Nuclear Medicine, 31: 376-378.
Bonte, F. J., Harris, T. S., Roney, C. A., and Hynan, L. S. (2004). Differential diagnosis between Alzheimer's and frontotemporal disease by the posterior cingulate sign. Journal of Nuclear Medicine, 45: 771-774.
Bonte, F. J., Weiner, M. F., Bigio, E. H., and White, C. L., 3rd. (1997). Brain blood flow in the dementias: SPECT with histopathologic correlation in 54 patients. Radiology, 202: 793-797.
Ceravolo, R., Volterrani, D., Gambaccini, G., Bernardini, S., Rossi, C., Logi, C. et al. (2004). Presynaptic nigro-striatal function in a group of Alzheimer's disease patients with parkinsonism: Evidence from a dopamine transporter imaging study. Journal of Neural Transmission, 111: 1065-1073.
Ceravolo, R., Volterrani, D., Gambaccini, G., Rossi, C., Logi, C., Manca, G. et al. (2003). Dopaminergic degeneration and perfusional impairment in Lewy body dementia and Alzheimer's disease. Neurological Sciences, 24: 162-163.
Chan, K. H., Johnson, K. A., Becker, J. A., Satlin, A., Mendelson, J., Garada, B. et al. (1994). A neural network classifier for cerebral perfusion imaging. Journal of Nuclear Medicine, 35: 771-774.
Charpentier, P., Lavenu, I., Defebvre, L., Duhamel, A., Lecouffe, P., Pasquier, F. et al. (2000). Alzheimer's disease and frontotemporal dementia are differentiated by discriminant analysis applied to (99m)Tc HmPAO SPECT data. Journal of Neurology, Neurosurgery, and Psychiatry, 69: 661-663.
Chetelat, G., Eustache, F., Viader, F., De La Sayette, V., Pelerin, A., Mezenge, F. et al. (2005). FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment. Neurocase, 11: 14-25.
Colloby, S. J., Fenwick, J. D., Williams, E. D., Paling, S. M., Lobotesis, K., Ballard, C. et al. (2002). A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. European Journal of Nuclear Medicine and Molecular Imaging, 29: 615-622.
De Oliveira, S. A., Castro, M. J., and Bittencourt, P. R. (1989). Slowly progressive aphasia followed by Alzheimer's dementia: a case report. Arquivos De neuro-Psiquiatria, 47: 72-75.
De Santi, S., de Leon, M. J., Rusinek, H., Convit, A., Tarshish, C. Y., Roche, A. et al. (2001). Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiology of Aging, 22: 529-539.
Doran, M., Vinjamuri, S., Collins, J., Parker, D., and Larner, A. J. (2005). Singlephoton emission computed tomography perfusion imaging in the differential diagnosis of dementia: a retrospective regional audit. International Journal of Clinical Practice, 59: 496-500.
Dougall, N., Nobili, F., and Ebmeier, K. P. (2004a). Predicting the accuracy of a diagnosis of Alzheimer's disease with 99mTc HMPAO single photon emission computed tomography. Psychiatry Research, 131: 157-168.
Dougall, N. J., Bruggink, S., and Ebmeier, K. P. (2004b). Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia. The American Journal of Geriatric Psychiatry, 12: 554-570.
Du, A. T., Jahng, G. H., Hayasaka, S., Kramer, J. H., Rosen, H. J., Gorno-Tempini, M. L. et al. (2006). Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology, 67: 1215-1220.
Ebmeier, K. P., Glabus, M. F., Prentice, N., Ryman, A., and Goodwin, G. M. (1998). A voxel-based analysis of cerebral perfusion in dementia and depression of old age. Neuroimage, 7: 199-208.
Eckert, T., Barnes, A., Dhawan, V., Frucht, S., Gordon, M. F., Feigin, A. S. et al. (2005). FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage, 26: 912-921.
Estorch, M., Camacho, V., Fuertes, J., Rodriguez-Revuelto, A., Hernandez, M. A., Flotats, A. et al. (2006). Dementia with Lewy bodies and Alzheimer's disease: differential diagnosis by cardiac sympathetic innervation MIBG imaging. Revista Española de Medicina Nuclear, 25: 229-235.
Filippi, L., Manni, C., Pierantozzi, M., Brusa, L., Danieli, R., Stanzione, P. et al. (2006). 123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study. Nuclear Medicine Communications, 27: 381-386.
Firbank, M. J., Colloby, S. J., Burn, D. J., McKeith, I. G., and O'Brien, J. T. (2003). Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage, 20: 1309-1319.
Foster, N. L., Gilman, S., Berent, S., Sima, A. A., D'Amato, C., Koeppe, R. A. et al. (1992). Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities. Journal of Neurology, Neurosurgery, and Psychiatry, 55: 707-713.
Foster, N. L., Heidebrink, J. L., Clark, C. M., Jagust, W. J., Arnold, S. E., Barbas, N. R., et al. (2007). FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain, 2007; 130: 2616-2635.
Galton, C. J., Patterson, K., Xuereb, J. H., Hodges, J. R. (2000). Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain, 123(Pt. 3): 484-498.
Garraux, G., Salmon, E., Degueldre, C., Lemaire, C., Laureys, S., and Franck, G. (1999). Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia. Neuroimage, 10: 149-162.
Garraux, G., Salmon, E., Peigneux, P., Kreisler, A., Degueldre, C., Lemaire, C. et al. (2000). Voxel-based distribution of metabolic impairment in corticobasal degeneration. Movement Disorders, 15: 894-904.
Gemmell, H. G., Sharp, P. F., Besson, J. A., Crawford, J. R., Ebmeier, K. P., Davidson, J. et al. (1987). Differential diagnosis in dementia using the cerebral blood flow agent 99mTc HM-PAO: A SPECT study. Journal of Computer Assisted Tomography, 11: 398-402.
Golan, H., Kremer, J., Freedman, M., and Ichise, M. (1996). Usefulness of follow-up regional cerebral blood flow measurements by single-photon emission computed tomography in the differential diagnosis of dementia. Journal of Neuroimaging, 6: 23-28.
Greene, J. D., Patterson, K., Xuereb, J., and Hodges, J. R. (1996). Alzheimer disease and nonfluent progressive aphasia. Archives of Neurology, 53: 1072-1078.
Hanada, K., Hosono, M., Kudo, T., Hitomi, Y., Yagyu, Y., Kirime, E. et al. (2006). Regional cerebral blood flow in the assessment of major depression and Alzheimer's disease in the early elderly. Nuclear Medicine Communications, 27: 535-541.
Hanyu, H., Shimizu, S., Hirao, K., Kanetaka, H., Iwamoto, T., Chikamori, T. et al. (2006). Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging, 33: 248-253.
Herholz, K., Bauer, B., Wienhard, K., Kracht, L., Mielke, R., Lenz, M. O. et al. (2000). In-vivo measurements of regional acetylcholine esterase activity in degenerative dementia: comparison with blood flow and glucose metabolism. Journal of Neural Transmission, 107: 1457-1468.
Herholz, K., Nordberg, A., Salmon, E., Perani, D., Kessler, J., Mielke, R. et al. (1999). Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 10: 494-504.
Higdon, R., Foster, N. L., Koeppe, R. A., DeCarli, C. S., Jagust, W. J., Clark, C. M. et al. (2004). A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer's disease using FDG-PET imaging. Statistics in Medicine, 23: 315-326.
Higuchi, M., Tashiro, M., Arai, H., Okamura, N., Hara, S., Higuchi, S. et al. (2000). Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies. Experimental Neurology, 162: 247-256.
Hodges, J. R. (2001). Frontotemporal dementia (Pick's disease): Clinical features and assessment. Neurology, 56: S6-S10.
Holman, B. L., Johnson, K. A., Gerada, B., Carvalho, P. A., and Satlin, A. (1992). The scintigraphic appearance of Alzheimer's disease: A prospective study using technetium-99m-HMPAO SPECT. Journal of Nuclear Medicine, 33: 181-185.
Honda, N., Machida, K., Hosono, M., Matsumoto, T., Matsuda, H., Oshima, M. et al. (2002). Interobserver variation in diagnosis of dementia by brain perfusion SPECT. Radiation Medicine, 20: 281-289.
Hosaka, K., Ishii, K., Sakamoto, S., Mori, T., Sasaki, M., Hirono, N. et al. (2002). Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration. Journal of the Neurolgical Sciences, 199: 67-71.
Ibach, B., Poljansky, S., Marienhagen, J., Sommer, M., Manner, P., and Hajak G. (2004). Contrasting metabolic impairment in frontotemporal degeneration and early onset Alzheimer's disease. Neuroimage, 23: 739-743.
Im, J. H., Chung, S. J., Kim, J. S., and Lee, M. C. (2006). Differential patterns of dopamine transporter loss in the basal ganglia of progressive supranuclear palsy and Parkinson's disease: analysis with [(123)I]IPT single photon emission computed tomography. Journal of the Neurological Sciences, 244: 103-109.
Imabayashi, E., Matsuda, H., Asada, T., Ohnishi, T., Sakamoto, S., Nakano, S. et al. (2004). Superiority of 3-dimensional stereotactic surface projection analysis over visual inspection in discrimination of patients with very early Alzheimer's disease from controls using brain perfusion SPECT. Journal of Nuclear Medicine, 45: 1450-1457.
Ince, G. (2001). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Aging Study (MRC CFAS). Lancet, 357: 169-175.
Ishii, K., Imamura, T., Sasaki, M., Yamaji, S., Sakamoto, S., Kitagaki, H. et al. (1998a). Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology, 51: 125-130.
Ishii, K., Sakamoto, S., Sasaki, M., Kitagaki, H., Yamaji, S., Hashimoto, M. et al. (1998b). Cerebral glucose metabolism in patients with frontotemporal dementia. Journal of Nuclear Medicine, 39: 1875-1878.
Jackson, M. and Lowe J. (1996). The new neuropathology of degenerative frontotemporal dementias. Acta Neuropathologica (Berlin), 91: 127-134.
Jagust, W., Reed, B. R., Mungas, D., Ellis, W., and DeCarli C. (2007). What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? Neurology, (in press).
Jagust, W. J., Friedland, R. P., and Budinger, T. F. (1985). Positron emission tomography with [18F]fluorodeoxyglucose differentiates normal pressure hydrocephalus from Alzheimer-type dementia. Journal of Neurology, Neurosurgery, and Psychiatry, 48: 1091-1096.
Jeong, Y., Chin, J., Tae, W. S., Hong, S. B., Kim, S. E., Suh, Y. L. et al. (2004). Serial positron emission tomography findings in a patient with hydrocephalic dementia and Alzheimer's disease. Journal of Neuroimaging, 2004; 14: 170-175.
Johnson, K. A., Jones, K., Holman, B. L., Becker, J. A., Spiers, P. A., Satlin, A. et al. (1998). Preclinical prediction of Alzheimer's disease using SPECT. Neurology, 50: 1563-1571.
Kemp, P. M., Hoffmann, S. A., Tossici-Bolt, L., Fleming, J. S., and Holmes, C. (2007). Limitations of the HMPAO SPECT appearances of occipital lobe perfusion in the differential diagnosis of dementia with Lewy bodies. Nuclear Medicine Communications, 28: 451-456.
Kerrouche, N., Herholz, K., Mielke, R., Holthoff, V., and Baron, J. C. (2006). 18FDG PET in vascular dementia: differentiation from Alzheimer's disease using voxel-based multivariate analysis. Journal of Cerebral Blood Flow and Metabolism, 26: 1213-1221.
Kertesz, A., Davidson, W., McCabe, P., Takagi, K., and Munoz, D. (2003). Primary progressive aphasia: diagnosis, varieties, evolution. Journal of the International Neuropsychological Society, 9: 710-719.
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P. et al. (2004). Imaging brain amyloid in Alzheimers disease with Pittsburgh Compound-B. Annals of Neurology, 55: 306-319.
Koeppe, R. A., Gilman, S., Joshi, A., Liu, S., Little, R., Junck, L. et al. (2005). 11C-DTBZ and 18F-FDG PET measures in differentiating dementias. Journal of Nuclear Medicine, 46: 936-944.
Kono, A. K., Ishii, K., Sofue, K., Miyamoto, N., Sakamoto, S., and Mori E. (2007). Fully automatic differential diagnosis system for dementia with Lewy bodies and Alzheimer's disease using FDG-PET and 3D-SSP. European Journal of Nuclear Medicine and Molecular Imaging, 34: 1490-1497.
Kreisler, A., Defebvre, L., Lecouffe, P., Duhamel, A., Charpentier, P., Steinling, M. et al. (2005). Corticobasal degeneration and Parkinson's disease assessed by HmPaO SPECT: The utility of factorial discriminant analysis. Movement Disorders, 20: 1431-1438.
Kuhl, D. E., Koeppe, R. A., Minoshima, S., Snyder, S. E., Ficaro, E. P., Foster, N. L. et al. (1999). In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology, 52: 691-699.
Kuwabara, Y., Ichiya, Y., Otsuka, M., Tahara, T., Fukumura, T., Gunasekera, R. et al. (1990). Differential diagnosis of bilateral parietal abnormalities in I-123 IMP SPECT imaging. Clinical Nuclear Medicine, 15: 893-899.
Launes, J., Sulkava, R., Erkinjuntti, T., Nikkinen, P., Lindroth, L., Liewendahl, K. et al. (1991). 99Tcm-HMPAO SPECT in suspected dementia. Nuclear Medicine Communications, 12: 757-765.
Lippa, C. F., Duda, J. E., Grossman, M., Hurtig, H. I., Aarsland, D., Boeve, B. F. et al. (2007). DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology, 68: 812-819.
Lobotesis, K., Fenwick, J. D., Phipps, A., Ryman, A., Swann, A., Ballard, C. et al. (2001). Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology, 56: 643-649.
Masterman, D. L., Mendez, M. F., Fairbanks, L. A., and Cummings, J. L. (1997). Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias. Journal of Geriatric Psychiatry and Neurology, 10: 15-21.
McKeith, I., OBrien, J., Walker, Z., Tatsch, K., Booij, J., Darcourt, J. et al. (2007). Sensitivity and specificity of dopamine transporter imaging with 123IFP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurology, 6: 305-313.
McNeill, R., Sare, G. M., Manoharan, M., Testa, H. J., Mann, D. M., Neary, D. et al. (2007). Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 78: 350-355.
Mielke, R., and Heiss, W. D. (1998). Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia. Journal of Neural Transmission. Supplementum, 53: 237-250.
Minoshima, S., Foster, N. L., Sima, A. A., Frey, K. A., Albin, R. L., and Kuhl, D. E. (2001). Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Annals of Neurology, 50: 358-365.
Mito, Y., Yoshida, K., Yabe, I., Makino, K., Hirotani, M., Tashiro, K. et al. (2005). Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease. Clinical Neurology and Neurosurgery, 107: 396-403.
Nestor, P. J., Graham, N. L., Fryer, T. D., Williams, G. B., Patterson, K., Hodges, J. R. (2003). Progressive non-fluent aphasia is associated with hypometabolism centred on the left anterior insula. Brain, 126: 2406-2418.
Newberg, A. B., Mozley, P. D., Sadek, A. H., Grossman, M., and Alavi A. (2000). Regional cerebral distribution of [Tc-99m] hexylmethylpropylene amineoxine in patients with progressive aphasia. Journal of Neuroimaging, 10: 162-168.
O'Brien, J. T., Colloby, S., Fenwick, J., Williams, E. D., Firbank, M., Burn, D. et al. (2004). Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Archives of Neurology, 61: 919-925.
Oyanagi, C., Katsumi, Y., Hanakawa, T., Hayashi, T., Thuy, D. D., Hashikawa, K. et al. (2002). Comparison of striatal dopamine D2 receptors in Parkinson's disease and progressive supranuclear palsy patients using [123I] iodobenzofuran single-photon emission computed tomography. Journal of Neuroimaging, 12: 316-324.
Pasquier, J., Michel, B. F., Brenot-Rossi, I., Hassan-Sebbag, N., Sauvan, R., Gastaut, J. L. (2002). Value of (99m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies. European Journal of Nuclear Medicine and Molecular Imaging, 29: 1342-1348.
Pickut, B. A., Saerens, J., Marien, P., Borggreve, F., Goeman, J., Vandevivere, J. et al. (1997). Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of the Alzheimer's type. Journal of Nuclear Medicine, 38: 929-934.
Pirker, W., Asenbaum, S., Bencsits, G., Prayer, D., Gerschlager, W., Deecke, L. et al. (2000). [123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. Movement Disorders, 15: 1158-1167.
Rabinovici, G. D., Furst, A. J., O'Neil, J. P., Racine, C. A., Mormino, E. C., Baker, S. L. et al. (2007). 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology, 68: 1205-1212.
Salmon, E., Garraux, G., Delbeuck, X., Collette, F., Kalbe, E., Zuendorf, G. et al. (2003). Predominant ventromedial frontopolar metabolic impairment in frontotemporal dementia. Neuroimage, 20: 435-440.
Scarmeas, N., Habeck, C. G., Zarahn, E., Anderson, K. E., Park, A., Hilton, J. et al. (2004). Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: Utility in group discrimination and correlations with functional performance. Neuroimage, 23: 35-45.
Seppi, K., Scherfler, C., Donnemiller, E., Virgolini, I., Schocke, M. F., Goebel, G. et al. (2006). Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis. Archives of Neurology, 63: 1154-60.
Shim, Y. S., Yang, D. W., Kim, B. S., Shon, Y. M., and Chung, Y. A. (2006). Comparison of regional cerebral blood flow in two subsets of subcortical ischemic vascular dementia: Statistical parametric mapping analysis of SPECT. Journal of the Neurological Sciences, 250: 85-91.
Shimizu, S., Hanyu, H., Kanetaka, H., Iwamoto, T., Koizumi, K., and Abe K. (2005). Differentiation of dementia with Lewy bodies from Alzheimer's disease using brain SPECT. Dementia and Geriatric Cognitive Disorders, 20: 25-30.
Shinotoh, H., Namba, H., Yamaguchi, M., Fukushi, K., Nagatsuka, S., Iyo, M., et al. (1999). Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy. Annals of Neurology, 46: 62-69.
Signorini, M., Paulesu, E., Friston, K., Perani, D., Colleluori, A., Lucignani, G. et al. (1999). Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping. Neuroimage, 9: 63-80.
Silverman, D. H., Small, G. W., Chang, C. Y., Lu, C. S., Kung De Aburto, M. A., Chen, W. et al. (2001). Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. The Journal of the American Medical Association, 286: 2120-2127.
Sjogren, M., Gustafson, L., Wikkelso, C., and Wallin A. (2000). Frontotemporal dementia can be distinguished from Alzheimer's disease and subcortical white matter dementia by an anterior-to-posterior rCBF-SPET ratio. Dementia and Geriatric Cognitive Disorders, 11: 275-285.
Small, G. W., Kepe, V., and Barrio, J. R. (2006a). Seeing is believing: neuroimaging adds to our understanding of cerebral pathology. Current Opinion in Psychiatry, 19: 564-569.
Small, G. W., Kepe, V., Ercoli, L. M., Siddarth, P., Bookheimer, S. Y., Miller, K. J., et al. (2006b). PET of brain amyloid and tau in mild cognitive impairment. The New England Journal of Medicine, 355: 2652-2663.
Spampinato, U., Habert, M. O., Mas, J. L., Bourdel, M. C., Ziegler, M., de Recondo, J. et al. (1991). (99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type. Journal of Neurology, Neurosurgery, and Psychiatry, 54: 787-792.
Staffen, W., Trinka, E., Iglseder, B., Pilz, P., Homann, N., and Ladurner G. (1997). Clinical and diagnostic findings in a patient with Creutzfeldt-Jakob disease (type Heidenhain). Journal of Neuroimaging, 7: 50-54.
Stoppe, G., Staedt, J., Kogler, A., Schutze, R., Kunert, H. J., Sandrock, D. et al. (1995). 99mTc-HMPAO-SPECT in the diagnosis of senile dementia of Alzheimer's type-a study under clinical routine conditions. Journal of Neural Transmission. General Section, 99: 195-211.
Talbot, P. R., Lloyd, J. J., Snowden, J. S., Neary, D., and Testa, H. J. (1998). A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia? Journal of Neurology, Neurosurgery, and Psychiatry, 64: 306-313.
Talbot, P. R., Snowden, J. S., Lloyd, J. J., Neary, D., and Testa, H. J. (1995). The contribution of single photon emission tomography to the clinical differentiation of degenerative cortical brain disorders. Journal of Neurology, 242: 579-586.
Testa, H. J., Snowden, J. S., Neary, D., Shields, R. A., Burjan, A. W., Prescott, M. C. et al. (1988). The use of [99mTc]-HM-PAO in the diagnosis of primary degenerative dementia. Journal of Cerebral Blood Flow and Metabolism, 8: S123-S126.
Van Laere, K., Casteels, C., De Ceuninck, L., Vanbilloen, B., Maes, A., Mortelmans, L. et al. (2006). Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis. Journal of Nuclear Medicine, 47: 384-392.
Vander Borght, T., Minoshima, S., Giordani, B., Foster, N. L., Frey, K. A., Berent, S. et al. (1997). Cerebral metabolic differences in Parkinsons and Alzheimers diseases matched for dementia severity. Journal of Nuclear Medicine, 38: 797-802.
Velakoulis, D. and Lloyd, J. H. (1998). The role of SPECT scanning in a neuropsychiatry unit. The Australian and New Zealand Journal of Psychiatry, 32: 511-522.
Walker, Z., Costa, D. C., Janssen, A. G., Walker, R. W., Livingstone, G., Katona, C. L. (1997). Dementia with lewy bodies: a study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon emission tomography. European Journal of Nuclear Medicine, 24: 609-614.
Walker, Z., Costa, D. C., Walker, R. W., Shaw, K., Gacinovic, S., Stevens, T. et al. (2002). Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand. Journal of Neurology, Neurosurgery, and Psychiatry, 73: 134-140.
Weisman, D. and McKeith, I. (2007). Dementia with Lewy bodies. Seminars in Neurology, 27: 42-47.
Yoshita, M. (1998). Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. Journal of Neurological Sciences, 155: 60-67.
Yoshita, M., Taki, J., and Yamada, M. (2001). A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies. Journal of Neurology, Neurosurgery, and Psychiatry, 71: 583-588.
Yoshita, M., Taki, J., Yokoyama, K., Noguchi-Shinohara, M., Matsumoto, Y., Nakajima, K. et al. (2006). Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD. Neurology, 66: 1850-1854.
Zahn, R., Buechert, M., Overmans, J., Talazko, J., Specht, K., Ko, C. W. et al. (2005). Mapping of temporal and parietal cortex in progressive nonfluent aphasia and Alzheimer's disease using chemical shift imaging, voxel-based morphometry and positron emission tomography. Psychiatry Research, 140: 115-131.
Zhang, L., Murata, Y., Ishida, R., Saitoh, Y., Mizusawa, H., and Shibuya H. (2001). Differentiating between progressive supranuclear palsy and corticobasal degeneration by brain perfusion SPET. Nuclear Medicine Communications, 22: 767-772.
